NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









IMBiologics

IMBiologics

Public
—N/Ahttps://imbiologics.com/

Last Round

Series B

Jul 24, 2023

Total Funding Raised

$19.14M

Company Overview

IMBiologics is a biotechnology company that develops immunomodulatory antibody therapeutics for the treatment of autoimmune diseases and cancer.

AI Layer

Non-AI

Keywords

biotechnologyantibody therapeuticsbispecific antibodyautoimmune diseasedrug discoverybiologicsfusion proteinclinical developmentinflammatory diseasebiotech R&Ddrug licensingbiotech startuppharma pipelinepreclinical research

IMBiologics Comps

Public and private peers based on sector, stage, and business model.

IMBiologics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

IMBiologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 24, 2023
SeedJan 19, 2021
View all Funding Rounds

IMBiologics Investors

Notable investors and investment history

IMBiologics investors
InvestorRounds
K2 Investment PartnersSeries B
Shinhan Venture InvestmentSeries B
Kingo Investment PartnersSeries B
KB InvestmentSeries B, Seed
Ard PartnersSeries B
Woori Financial GroupSeries B
Yuanta SecuritiesSeries B
View all Investors

IMBiologics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

IMBiologics Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—
Employee Range7
Year Founded2020
Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.